ANAPC7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.466800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.841200E-01
Normal-vs-Stage2
2.439600E-01
Normal-vs-Stage3
8.713700E-02
Normal-vs-Stage4
1.672420E-01
Stage1-vs-Stage2
1.114170E-01
Stage1-vs-Stage3
4.206400E-02
Stage1-vs-Stage4
1.684370E-01
Stage2-vs-Stage3
7.433700E-02
Stage2-vs-Stage4
7.571800E-01
Stage3-vs-Stage4
2.192600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.018200E-01
Normal-vs-AfricanAmerican
1.842990E-01
Normal-vs-Asian
9.843700E-02
Caucasian-vs-AfricanAmerican
4.830400E-01
Caucasian-vs-Asian
2.822800E-01
AfricanAmerican-vs-Asian
9.096400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.186200E-01
Normal-vs-Female
2.806800E-01
Male-vs-Female
4.632800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.673600E-01
Normal-vs-Age(41-60Yrs)
3.836200E-01
Normal-vs-Age(61-80Yrs)
3.186200E-01
Normal-vs-Age(81-100Yrs)
6.045000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.310600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.895600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.625200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.769200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.450200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.505000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.873000E-01
Normal-vs-Daily Drinker
1.099040E-01
Normal-vs-Weekly Drinker
4.822000E-01
Normal-vs-Occasional Drinker
9.143600E-01
Normal-vs-Social Drinker
4.214000E-01
Non Drinker-vs-Daily Drinker
7.694000E-01
Non Drinker-vs-Weekly Drinker
6.145200E-01
Non Drinker-vs-Occasional Drinker
8.994100E-02
Non Drinker-vs-Social Drinker
4.828400E-01
Daily Drinker-vs-Weekly Drinker
4.162400E-01
Daily Drinker-vs-Occasional Drinker
5.991900E-02
Daily Drinker-vs-Social Drinker
2.649400E-01
Weekly Drinker-vs-Occasional Drinker
3.454200E-01
Weekly Drinker-vs-Social Drinker
9.021800E-01
Occasional Drinker-vs-Social Drinker
3.515400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.349800E-01
Normal-vs-Grade 2
9.076600E-01
Normal-vs-Grade 3
8.933400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.160000E-01
Grade 1-vs-Grade 3
5.444800E-01
Grade 1-vs-Grade 4
6.349800E-01
Grade 2-vs-Grade 3
7.149000E-01
Grade 2-vs-Grade 4
9.076600E-01
Grade 3-vs-Grade 4
8.933400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.047000E-01
Normal-vs-NonDiabetic
3.596800E-01
Diabetic-vs-NonDiabetic
4.488200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.174570E-01
Normal-vs-NoPancreatitis
3.532400E-01
Pancreatitis-vs-NoPancreatitis
5.272200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.455000E-01
Normal-vs-N1
2.597400E-01
N0-vs-N1
3.412600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.784600E-01
Normal-vs-TP53-NonMutant
7.157600E-01
TP53-Mutant-vs-TP53-NonMutant
6.317600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
